ICU MEDICAL INC (ICUI) Stock Fundamental Analysis
NASDAQ:ICUI - Nasdaq - US44930G1076 - Common Stock
Overall ICUI gets a fundamental rating of 3 out of 10. We evaluated ICUI against 191 industry peers in the Health Care Equipment & Supplies industry. ICUI may be in some trouble as it scores bad on both profitability and health. ICUI is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
ICUI had positive earnings in the past year.
In the past year ICUI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ICUI reported negative net income in multiple years.
Of the past 5 years ICUI 4 years had a positive operating cash flow.
1.2 Ratios
ICUI has a better Return On Assets (-2.58%) than 66.84% of its industry peers.
The Return On Equity of ICUI (-5.42%) is better than 67.89% of its industry peers.
ICUI has a better Return On Invested Capital (1.13%) than 67.89% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ICUI is significantly below the industry average of 8.08%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.58% | ||
| ROE | -5.42% | ||
| ROIC | 1.13% |
ROA(3y)1.05%
ROA(5y)2.81%
ROE(3y)0.48%
ROE(5y)2.91%
ROIC(3y)2.84%
ROIC(5y)5.09%
1.3 Margins
ICUI has a better Operating Margin (2.30%) than 67.89% of its industry peers.
ICUI's Operating Margin has declined in the last couple of years.
ICUI has a Gross Margin of 32.87%. This is in the lower half of the industry: ICUI underperforms 71.05% of its industry peers.
In the last couple of years the Gross Margin of ICUI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.3% | ||
| PM (TTM) | N/A | ||
| GM | 32.87% |
OM growth 3Y-34.03%
OM growth 5Y-25.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5Y-4.26%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICUI is destroying value.
ICUI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ICUI has more shares outstanding
The debt/assets ratio for ICUI is higher compared to a year ago.
2.2 Solvency
ICUI has an Altman-Z score of 2.08. This is not the best score and indicates that ICUI is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.08, ICUI is in line with its industry, outperforming 60.00% of the companies in the same industry.
ICUI has a debt to FCF ratio of 10.01. This is a negative value and a sign of low solvency as ICUI would need 10.01 years to pay back of all of its debts.
The Debt to FCF ratio of ICUI (10.01) is better than 72.11% of its industry peers.
A Debt/Equity ratio of 0.75 indicates that ICUI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.75, ICUI is doing worse than 71.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.75 | ||
| Debt/FCF | 10.01 | ||
| Altman-Z | 2.08 |
ROIC/WACC0.13
WACC8.55%
2.3 Liquidity
A Current Ratio of 2.29 indicates that ICUI has no problem at all paying its short term obligations.
ICUI has a Current ratio (2.29) which is in line with its industry peers.
A Quick Ratio of 1.03 indicates that ICUI should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.03, ICUI is doing worse than 75.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.29 | ||
| Quick Ratio | 1.03 |
3. Growth
3.1 Past
ICUI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.35%.
Measured over the past years, ICUI shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.22% on average per year.
Looking at the last year, ICUI shows a small growth in Revenue. The Revenue has grown by 4.04% in the last year.
The Revenue has been growing by 10.04% on average over the past years. This is quite good.
EPS 1Y (TTM)-16.35%
EPS 3Y-1.76%
EPS 5Y-5.22%
EPS Q2Q%1.27%
Revenue 1Y (TTM)4.04%
Revenue growth 3Y21.13%
Revenue growth 5Y10.04%
Sales Q2Q%7.78%
3.2 Future
Based on estimates for the next years, ICUI will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.03% on average per year.
Based on estimates for the next years, ICUI will show a small growth in Revenue. The Revenue will grow by 1.29% on average per year.
EPS Next Y-15.48%
EPS Next 2Y3.72%
EPS Next 3Y8.82%
EPS Next 5Y14.03%
Revenue Next Year4.47%
Revenue Next 2Y2.39%
Revenue Next 3Y2.59%
Revenue Next 5Y1.29%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 29.38, which means the current valuation is very expensive for ICUI.
Based on the Price/Earnings ratio, ICUI is valued a bit cheaper than 76.84% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.29. ICUI is around the same levels.
With a Price/Forward Earnings ratio of 22.95, ICUI is valued on the expensive side.
Based on the Price/Forward Earnings ratio, ICUI is valued a bit cheaper than 80.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 24.44. ICUI is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.38 | ||
| Fwd PE | 22.95 |
4.2 Price Multiples
81.05% of the companies in the same industry are more expensive than ICUI, based on the Enterprise Value to EBITDA ratio.
ICUI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ICUI is cheaper than 87.37% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.6 | ||
| EV/EBITDA | 19.08 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.72%
EPS Next 3Y8.82%
5. Dividend
5.1 Amount
No dividends for ICUI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ICU MEDICAL INC
NASDAQ:ICUI (1/21/2025, 8:06:50 PM)
After market: 166.87 0 (0%)166.87
+3 (+1.83%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners98.32%
Inst Owner Change-0.02%
Ins Owners1.04%
Ins Owner Change-0.29%
Market Cap4.08B
Analysts81.82
Price Target213.95 (28.21%)
Short Float %3.71%
Short Ratio3.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.95%
Min EPS beat(2)24.67%
Max EPS beat(2)53.22%
EPS beat(4)4
Avg EPS beat(4)30.44%
Min EPS beat(4)14.78%
Max EPS beat(4)53.22%
EPS beat(8)8
Avg EPS beat(8)21.02%
EPS beat(12)11
Avg EPS beat(12)14.58%
EPS beat(16)15
Avg EPS beat(16)13.81%
Revenue beat(2)2
Avg Revenue beat(2)1.69%
Min Revenue beat(2)0.5%
Max Revenue beat(2)2.87%
Revenue beat(4)3
Avg Revenue beat(4)0.43%
Min Revenue beat(4)-1.9%
Max Revenue beat(4)2.87%
Revenue beat(8)3
Avg Revenue beat(8)-2.12%
Revenue beat(12)5
Avg Revenue beat(12)-1.2%
Revenue beat(16)9
Avg Revenue beat(16)0.23%
PT rev (1m)0.55%
PT rev (3m)29.48%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.11%
EPS NY rev (1m)0%
EPS NY rev (3m)7.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.38 | ||
| Fwd PE | 22.95 | ||
| P/S | 1.75 | ||
| P/FCF | 25.6 | ||
| P/OCF | 16.01 | ||
| P/B | 1.99 | ||
| P/tB | N/A | ||
| EV/EBITDA | 19.08 |
EPS(TTM)5.68
EY3.4%
EPS(NY)7.27
Fwd EY4.36%
FCF(TTM)6.52
FCFY3.91%
OCF(TTM)10.42
OCFY6.25%
SpS95.59
BVpS83.68
TBVpS-8.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.58% | ||
| ROE | -5.42% | ||
| ROCE | 1.43% | ||
| ROIC | 1.13% | ||
| ROICexc | 1.24% | ||
| ROICexgc | 3.61% | ||
| OM | 2.3% | ||
| PM (TTM) | N/A | ||
| GM | 32.87% | ||
| FCFM | 6.82% |
ROA(3y)1.05%
ROA(5y)2.81%
ROE(3y)0.48%
ROE(5y)2.91%
ROIC(3y)2.84%
ROIC(5y)5.09%
ROICexc(3y)4.01%
ROICexc(5y)6.78%
ROICexgc(3y)6.07%
ROICexgc(5y)9.15%
ROCE(3y)3.59%
ROCE(5y)6.44%
ROICexcg growth 3Y-28.58%
ROICexcg growth 5Y-25.74%
ROICexc growth 3Y-45.47%
ROICexc growth 5Y-37.56%
OM growth 3Y-34.03%
OM growth 5Y-25.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5Y-4.26%
F-Score4
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.75 | ||
| Debt/FCF | 10.01 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 42.73% | ||
| Cap/Sales | 4.08% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 91.92% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.29 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 2.08 |
F-Score4
WACC8.55%
ROIC/WACC0.13
Cap/Depr(3y)57.9%
Cap/Depr(5y)85.76%
Cap/Sales(3y)4.89%
Cap/Sales(5y)6.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.35%
EPS 3Y-1.76%
EPS 5Y-5.22%
EPS Q2Q%1.27%
EPS Next Y-15.48%
EPS Next 2Y3.72%
EPS Next 3Y8.82%
EPS Next 5Y14.03%
Revenue 1Y (TTM)4.04%
Revenue growth 3Y21.13%
Revenue growth 5Y10.04%
Sales Q2Q%7.78%
Revenue Next Year4.47%
Revenue Next 2Y2.39%
Revenue Next 3Y2.59%
Revenue Next 5Y1.29%
EBIT growth 1Y-28.24%
EBIT growth 3Y-20.09%
EBIT growth 5Y-18.37%
EBIT Next Year25.87%
EBIT Next 3Y15.33%
EBIT Next 5Y11.53%
FCF growth 1Y305.62%
FCF growth 3Y-16.01%
FCF growth 5Y4.08%
OCF growth 1Y1049.29%
OCF growth 3Y-9.31%
OCF growth 5Y0.74%